Friday, January 27, 2017 - 12:00pm
Gary Hattersley, PhD
Chief Scientific Officer
Radius Health, Inc.
“Abaloparatide: skeletal effects and mechanisms”
FRIDAY, JANUARY 27, 2017
12:00 NOON – 1:00 PM
SCHOOL OF DENTISTRY
Gary Hattersley, Ph.D., currently serves as Chief Scientific Officer Radius Health, a company with a late-stage bone-anabolic agent in development for the treatment of postmenopausal osteoporosis. Before joining Radius Health, Dr. Hattersley worked for Millennium Pharmaceuticals and Genetics Institute and received a Ph.D. in Experimental Pathology from St. George’s Hospital Medical School.
Hosted by the McCauley Lab. Questions call Kim Huner, 763-3311